Introduction
The centrosome is a microtubule-organizing center that has a crucial function in cell division (Kirschner and Mitchison, 1986) . Interphase cells have a single centrosome that is typically located near the nucleus and contains a pair of centrioles that anchor the recruitment of pericentriolar material including the microtubulenucleating protein g-tubulin (Joshi et al., 1992) . The centrosome is replicated once, and once only, during the cell cycle to give rise to two centrosomes that function as the spindle poles of the dividing cells (Kellogg, 1989) . Its key role is to help organize the mitotic spindle, a collection of protein filaments that pull the duplicated chromosomes apart during cell division, thereby ensuring that each daughter cell receives a complete set. Without the centrosome, normal division will not occur.
Recent studies have implicated a role for centrosome amplification in the pathogenesis of human cancers (Lingle et al., 1998; Pihan et al., 1998; Weber et al., 1998; Sato et al., 1999; Kuo et al., 2000) . The term 'centrosome amplification' is commonly used to describe centrosomes that appear significantly larger than normal (as defined by staining of structural centrosome components, such as g-tubulin, which exceeds that seen in the corresponding normal tissue or cell type), centrosomes that contain an abnormal number of centrioles, or the presence of more than two centrosomes in a single cell (Lingle and Salisbury, 1999; Schatten et al., 2000) . Numerous studies have also implicated centrosome amplification as a potential origin of chromosomal instability in the development of a variety of human tumors (Pihan et al., 1998; Ghadimi et al., 2000; Pihan et al., 2001; Sato et al., 2001; Lingle et al., 2002; Weaver et al., 2002; Al-Romaih et al., 2003; Mayer et al., 2003; Pihan et al., 2003; Bennett et al., 2004) . In a study performed in breast cancer, centrosome abnormalities (in size and number) occurred early in the tumorigenic process and were directly correlated with aneuploidy, which can be evidence of chromosomal instability (Lingle et al., 2002) . Another study in colorectal cancer cell lines showed that centrosome amplification occurred in aneuploid, but not diploid, cells and was correlated with chromosomal aberrations (Ghadimi et al., 2000) .
The tumor suppressor p53 is frequently mutated in human cancers (Hollstein et al., 1991) . Its inactivation has been correlated with genetic instability (Carder et al., 1993; Harvey et al., 1993; Lee et al., 1994; Donehower et al., 1996) . Importantly, loss of p53 has been implicated in centrosome amplification. Thus, mouse embryonic fibroblasts (MEFs) obtained from mice null for the p53 alleles contained multiple centrosomes, abnormally formed mitotic spindles, and genomic instability as manifested by aneuploidy (Fukasawa et al., 1996; Fukasawa et al., 1997; . The centrosome amplification in p53-null MEFs was synergistically induced by overexpression of cyclin E (Mussman et al., 2000) , which is a key regulator of centrosome duplication in the G 1 phase of the cell cycle (Hinchcliffe et al., 1999; Hinchcliffe and Sluder, 2002) . Centrosome amplification is also observed in human cancers with mutated p53, either alone (Carroll et al., 1999; Ouyang et al., 2001) or with overexpression of cyclin E (Kawamura et al., 2004) .
p53 is a sequence-specific transcription factor that exerts its cellular effects by modulating expression of a host of genes (Vogelstein et al., 2000) . An example of a p53 target gene is one that encodes the cyclin-dependent kinase inhibitor, p21 WAF1/CIP1 (el-Deiry et al., 1993; Waldman et al., 1995) . We previously demonstrated that the gene encoding Kru¨ppel-like factor 4 (KLF4, also known as gut-enriched Kru¨ppel-like factor or GKLF) (Garrett-Sinha et al., 1996; Shields et al., 1996) is transcriptionally activated by p53 following DNA damage (Zhang et al., 1998) . The induction of KLF4 consequently causes cell cycle arrest at both the G 1 /S and G 2 /M boundaries (Yoon et al., 2003; Yoon and Yang, 2004) . These results implicate KLF4 as an important factor in mediating the checkpoint function of p53 upon DNA damage. Indeed, KLF4 has been shown to be a potential tumor suppressor in colorectal cancer (Zhao et al., 2004) . Here, we present evidence for an equally important role of KLF4 in preventing centrosome amplification after DNA damage caused by g-irradiation.
Results g-Irradiation leads to centrosome amplification in the absence of p53
We first determined whether centrosome amplification occurs in HCT116 cells following g-irradiation. HCT116 p53 þ / þ and p53À/À cells (Bunz et al., 1998) were irradiated with 12 Gy g-ray and stained for centrosomes using a g-tubulin antibody 2 days later. Figure 1 shows an example of HCT116 p53À/À cells with 1, 2, 3, and >4 centrosomes after irradiation, with the latter two cells exhibiting evidence of centrosome amplification. After quantifying the numbers of cells with 1, 2, or X3 centrosomes, it became apparent that HCT116 p53À/À, but not HCT116 p53 þ / þ , cells exhibited centrosome amplification after g-irradiation (Figure 2b and a, respectively). These results indicate that p53 is required for the maintenance of centrosome stability in HCT116 cells following g-ray-induced DNA damage.
Conditional expression of KLF4 reduces centrosome amplification after g-irradiation in the absence of p53
Previous studies indicated that KLF4 failed to be induced in HCT116 p53À/À cells after g-irradiation due to the absence of p53 (Yoon et al., 2003; Yoon and Yang, 2004) . To determine whether conditional induction of exogenous KLF4 can suppress radiation-induced centrosome amplification, we infected HCT116 p53À/À cells containing stably transfected EcR (EcR116 p53À/À) with recombinant adenoviruses designed to express an inducible KLF4, AdEGI-KLF4 (Yoon et al., 2003; Yoon and Yang, 2004) . As shown in Figure 2c , there was a significant reduction in the percentage of cells exhibiting centrosome amplification in infected cells that had been irradiated and treated with the inducer, ponasterone A. These results suggest that re-expression of KLF4 can suppress centrosome amplification from g-irradiation even in the absence of p53.
g-Irradiation causes centrosome amplification when KLF4 expression is inhibited even in the presence of wild-type p53
To further demonstrate that KLF4 is required for the maintenance of centrosome stability following DNA damage, we established stably transfected HCT116 p53 þ / þ cells with reduced KLF4 expression using small hairpin RNA (shRNA). Two independent clones of cells were obtained and named KLF4/sh2-1 and KLF4/sh2-2, respectively. As shown in Figure 3 , both cell lines exhibited reduced induction in KLF4 following g-irradiation, with the sh2-2 cell line having a greater degree of inhibition than sh2-1 (lanes 4 and 6). Importantly, the lack of KLF4 induction in the two cells was accompanied by a failure of p21
, but not p53, induction (lanes 4 and 6). In contrast, HCT116 p53 þ / þ cells that had been transfected with the vector alone (sh-vector) exhibited the normal response to girradiation for p53, KLF4, and p21 WAF1/CIP1 (lanes 2). These results are consistent with our previous observations that KLF4 is necessary for mediating the effect of p53 in inducing p21
. To demonstrate that inhibition of KLF4 results in an altered response of cells to DNA damage, we irradiated the KLF4 sh2-2 cells with 12 Gy g-ray and scored mitotic indices 2 days following irradiation. As seen in Figure 4a , irradiated KLF4 sh2-2 cells contained a higher percentage of cells in mitosis when compared to unirradiated cells. This result is consistent with our previous study that transient inhibition of KLF4 using small interfering RNA (siRNA) led to an increase in mitotic entry following g-irradiation (Yoon and Yang, 2004) . Importantly, inhibition of KLF4 expression due to RNA interference resulted in an increase in centrosome amplification after g-irradiation ( Figure 4b ) in a manner similar to that in HCT116 p53À/À cells ( Figure 2b ).
Inhibition of KLF4 expression results in increased cyclin E level and Cdk2 activity after g-irradiation
To determine the mechanism by which KLF4 prevents centrosome amplification following DNA damage, we measured the levels of cyclin E in various cells with or without irradiation. Cyclin E is known to be a crucial factor in regulating centrosome duplication (Tokuyama et al., 2001; Hinchcliffe and Sluder, 2002; Kawamura et al., 2004) . As seen in Figure 5a , while the levels of cyclin E remained largely unchanged after irradiation in HCT116 p53 þ / þ cells and HCT116 p53 þ / þ cells stably transfected with a sh-vector (lanes 1 and 2, and 5 and HCT116 p53À/À cells were irradiated with 12 Gy g-ray and stained for centrosomes using a g-tubulin antibody 2 days later. Examples of a cell with 1, 2, 3, or >4 centrosomes are shown. Nucleus was counterstained with Topro3 6, respectively), the levels of cyclin E were significantly increased in irradiated HCT116 p53À/À and HCT116 KLF4/sh2-2 cells when compared to unirradiated cells (lanes 3 and 4, and 7 and 8, respectively). Moreover, the Cdk2 activity was also elevated in irradiated HCT116 p53À/À and HCT116 KLF4/ sh2-2 cells when compared to unirradiated cells ( Figure 5b ; lanes 3 and 4, and 7 and 8, respectively). Importantly, the elevated cyclin E level and Cdk2 activity due to irradiation in both cells were correlated with centrosome amplification (Figures 2b  and 4b ). Mitotic indices and centrosome profiles of HCT116 KLF4/sh2-2 cells with and without irradiation. HCT116 KLF4/ sh2-2 cells were irradiated ( þ g) or not (Àg) (a) on day 0 and maintained in culture for 2 days before being examined for the presence of mitotic figures. N ¼ 4. *Po0.01. In (b), the cells were irradiated ( þ g) or not (Àg) on day 0 and maintained in culture for 2 days before staining for centrosomes. A total of 300 cells were examined in each experiment and the experiments were repeated two additional times for a total N of 3. *Po0.01
KLF4 overexpression inhibits cyclin E expression and promoter activity
To further determine how KLF4 may influence cyclin E and Cdk2 activity, we performed cotransfection experiments in HCT116 p53À/À cells using a À363 cyclin E-luciferase reporter (Geng et al., 1996) and an expression vector containing KLF4, PMT3-KLF4 (Shields et al., 1996; Shields and Yang, 1997) . Figure 6a shows that the reporter activity was significantly reduced in cells transfected with PMT3-KLF4 as compared to those transfected with the PMT3 vector alone (lanes 1 and 2) . Similarly, conditional induction of KLF4 in irradiated EcR116 p53À/À cells infected with AdEGI-KLF4 resulted in a reduction in the level of cyclin E (Figure 6b ; compare lane 1 and 2). These results indicate that, when overexpressed, KLF4 is an inhibitor of cyclin E transcription.
Discussion
The duplication of centrosomes is a carefully choreographed event during progression of the cell cycle. In mammalian cells, the centrosome reproduces only once during interphase, thus ensuring a strictly bipolar spindle axis during mitosis (Hinchcliffe and Sluder, 2001 ). Since there is not a checkpoint in the cell cycle that monitors defects in the number of spindles (Sluder et al., 1997) , dysregulated centrosome duplication can lead to genomic instability due to the formation of multipolar mitotic spindles. This is consistent with reports that document a direct correlation between centrosome abnormalities (in size and number) with chromosomal instability in several human cancers (Ghadimi et al., 2000; Pihan et al., 2001; Sato et al., 2001; Lingle et al., 2002) .
It is now well established that centrosome duplication is largely controlled by the Cdk2-cyclin E complex (Hinchcliffe and Sluder, 2001; Hinchcliffe and Sluder, 2002) . Cdk2-cyclin E activity rises shortly before the onset of S phase, which is the time when evidence of centrosome duplication first appears (Hinchcliffe et al., 1999) . This is supported by the finding that inactivation of the Cdk2 inhibitor, p21
, results in increased Cdk2 activity and allows the cells to accumulate multiple centrosomes (Mantel et al., 1999) . It is also supported by the finding that mutations in the tumor suppressor p53, which directly activates p21 WAF1/CIP1 , result in centrosome amplification (Fukasawa et al., 1996) . However, there appears to be a difference between human and mouse cells with regard to the effect of p53 mutation on centrosome duplication. In MEFs, deletion of p53 alone is sufficient to cause centrosome duplication (Fukasawa et al., 1996) . In contrast, inactivation of p53 in normal human fibroblasts does not result in significant centrosome amplification or chromosomal instability (Bunz et al., 2002; Duensing et al., 2000) . The reason behind this discrepancy is thought to reside in the activity of cyclin E. In cultured normal human cells, cyclin E expression is strictly controlled and limited to a short period at late G 1 phase (Ekholm et al., 2001) . In contrast, in cultured mouse cells, cyclin E expression is less stringently controlled, and increased cyclin E activity can often be seen in early G 1 phase (Kawamura et al., 2004) . A reason for the difference in expression of cyclin E between human and mouse is the divergence in the regulatory sequences between the two cyclin E promoters (Ohtani et al., 1995; Botz et al., 1996) . Our finding that under baseline (unirradiated) conditions, both HCT116 p53 þ / þ and À/À cells had relatively similar is consistent with these previous observations. Following g-irradiation, HCT116 p53À/À but not p53 þ / þ cells exhibited evidence of centrosome amplification (Figures 1 and 2a and b) . Previous studies also demonstrated that HCT116 p53 þ / þ cells arrested in G 2 phase following irradiation, while p53À/À cells continued into mitosis (Bunz et al., 1998; Yoon and Yang, 2004) . These findings highlighted the importance of p53 in maintaining DNA damage-induced checkpoint functions and centrosome duplication. A reason for the increasing number of centrosomes after irradiation of p53-null cells could be due to the inability of these cells to complete cytokinesis (Bunz et al., 1998) . However, our study also revealed that irradiated p53À/À cells contained a higher cyclin E level than unirradiated cells (Figure 5a ). This could contribute to the observed higher Cdk2 activity in irradiated p53À/À cells (Figure 5b ), although another factor could be the previously observed lack of induction in p21
after irradiation of cells lacking p53 (Yoon et al., 2003; Yoon and Yang, 2004) . Be that as it may, our study clearly showed that p53 is crucial for preventing centrosome amplification from g-irradiation-induced DNA damage.
Our study identified KLF4 as an important mediator of p53 in maintaining centrosome stability following g-irradiation. Thus, in the absence of p53, inducible expression of KLF4 inhibited centrosome amplification in irradiated cells (Figure 2c) . Conversely, stable suppression of KLF4 in cells with wild-type p53 was associated with centrosome amplification after g-irradiation (Figure 4b ). Together, these data indicate that KLF4 is both necessary and sufficient for preventing centrosome amplification following DNA damage. As with p53, irradiated cells with reduced KLF4 contained an elevated level of cyclin E and Cdk2 activity ( Figure 5 ). Our study also showed that overexpression of KLF4 reduced the level of cyclin E (Figure 6b ), which is in part due to the ability of KLF4 to suppress the cyclin E promoter activity (Figure 6a ). In addition, previous studies indicate that KLF4 is required for the induction of p21 WAF1/CIP1 expression in a p53-dependent manner (Zhang et al., 2000; Yoon et al., 2003; Yoon and Yang, 2004) . This effect must also have contributed to the increase in Cdk2 activity in irradiated cells with reduced KLF4 (Figure 5 ). Taken together, these findings support a crucial role for KLF4 in regulating centrosome duplication upon DNA damage.
The significance of KLF4 in checkpoint control is further demonstrated by the recent observation that KLF4 is inactivated by either allelic loss or promoter methylation in a subset of human colorectal cancer specimens (Zhao et al., 2004) . In tumors with reduced KLF4 expression, KLF4 could be viewed as a tumor suppressor (Zhao et al., 2004) . Thus, the lack of crucial checkpoint functions due to the reduction in KLF4 expression may potentially contribute to the tumor phenotype. Although we have not examined tumors with reduced KLF4 expression for evidence of centrosome amplification, we noticed that a particular colorectal cancer cell line, RKO, known to contain exceedingly low level of KLF4 mRNA Zhao et al., 2004) , exhibited evidence of centrosome amplification after g-irradiation (Ghaleb and Yang, unpublished observation). As centrosome amplification has been implicated as a factor leading to chromosomal instability in cancer (Pihan et al., 1998; Weber et al., 1998; Ghadimi et al., 2000; Sato et al., 2001; Lingle et al., 2002; Al-Romaih et al., 2003; Mayer et al., 2003; Pihan et al., 2003) , it is formally possible that tumors with diminished expression of KLF4 may also exhibit chromosomal instability. Indeed, recent experiments in our lab have shown that shRNA-mediated reduction of KLF4 increases formation of polyploid and subsequent aneuploid cells upon treatment with the microtubule inhibitor nocodazole, thereby suggesting a role for KLF4 in protection against, at the very least exogenously induced, chromosomal instability. Previous studies from our group have also placed KLF4 as an effector downstream from the tumor suppressor APC in colorectal cancer cells, further suggesting the KLF4 may be involved in maintaining genomic stability in an APCdependent fashion . Investigations of mechanisms of how KLF4 may affect genomic stability are currently underway.
Materials and methods

Cell lines
The colon cancer cell lines wild type and null for p53, HCT116 p53 þ / þ and HCT116 p53À/À, respectively, were generous gifts of Dr Bert Vogelstein of Johns Hopkins University (Bunz et al., 1998) . The cells were cultured in McCoy's medium supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin. EcR116 p53À/À cells were generated by stably transfecting pVgRXR (Chen et al., 2001) , which contains VgEcR and RXR that form the receptor for the insect hormone, ecdysone, into the parental HCT116 p53À/À cells and selected with Zeocin (Yoon et al., 2003; Yoon and Yang, 2004) .
g-Irradiation
g-irradiation of cultured cells was performed using a 137 Cs g-irradiator at 0.8 Gy/min for 15 min, for a total of 12 Gy (Yoon et al., 2003; Yoon and Yang, 2004) . Media were changed every 24 h until cells were harvested for analysis.
Centrosome immunostaining
Cells grown on coverslips were cooled on ice and washed with cold phosphate-buffered saline (PBS). They were then fixed with cold 100% methanol and placed at À201C for 15 min. Afterwards, cells were washed twice with cold PBS and placed in a 0.5% bovine serum albumin (BSA) solution for 1 h at 41C. FITC-conjugated g-tubulin antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) was then added to a final concentration of 10 mg/ml and the cells were incubated for 2 h at 41C. After the incubation, cells were washed twice with cold PBS and counterstained with ToPro3 (Molecular Probes, Eugene, OR, USA) for 5 min at room temperature in the dark. Cells were then washed five times with cold PBS and then with ddH 2 O. Cells were mounted using ProLong Antifade kit (Molecular Probes), sealed and visualized with a Zeiss 510 confocal microscope. For each experiment, 300 cells with visible centrosomes were counted and grouped based on whether they had 1, 2, or X3 centrosomes per cell.
Measurement of mitotic indices
Cells grown on coverslips were fixed in 3% formaldehyde for 15 min. Cold 100% methanol was then added and cells were incubated at room temperature for 20 min. Cells were then rinsed three times with Dulbecco's phosphate-buffered saline (DPBS). A Hoechst 33258 solution (10 mg/ml) was added to a final concentration of 0.2 mg/ml and the cells were incubated at room temperature for 15 min. After the incubation, cells were rinsed five times with DPBS and the nuclei were visualized by fluorescence microscopy (Nikon, Melville, NY, USA). A minimum of 300 cells was examined per experiment. Mitotic figures were scored for cells with condensed chromosomes (Yoon and Yang, 2004) .
Adenovirus infection
The recombinant adenovirus containing green fluorescence protein (GFP) and KLF4, AdEGI-KLF4, was described previously (Chen et al., 2001) . EcR116 p53À/À cells were grown to 40% confluence in 10-cm dishes and replenished with fresh media containing 2% FBS followed by the addition of 10 8 plaque forming units of recombinant virus per dish. Infected cells were incubated at 371C for 6 h, at which time cells were g-irradiated and the media changed. Cells were treated with 5 mM ponasterone A (Invitrogen, Carlsbad, CA, USA) for 48 h and then collected for further analysis.
Preparation of shRNA and stable transfection
Single-stranded DNAs (of 65 nucleotides) were produced by Sigma Genosys (Sigma Genosys, The Woodlands, TX) with the following sequences: 5 0 -GATCCCGTTGGACCCGGTGTA CATTCTTCAAGAGAGAATGTACACCGGGTCCAATTT TTTGGAAA-3 0 and 5 0 -AGCTTTTCCAAAAAATTGGAC CCGGTGTACATTCTCTCTTGAAGAATGTACACCGGG TCCAACGG-3 0 . The single-stranded DNA was dissolved in 10 mM Tris-HCl, pH 7.5, 50 mM NaCl, and 1 mM EDTA. The complementary oligonucleotides were mixed at equimolar concentration and heated to 951C in a standard heat block for 15 min. Heat block was then removed from the apparatus and allowed to cool to room temperature. The annealed DNA was then inserted to pSilencer 3.1-H1 hygro (Ambion Inc., Austin, TX, USA) between the BamHI and HindIII sites. Positive clones were identified by DNA sequencing and plasmid DNA was amplified and purified. They were then linearized by XmnI restriction enzyme (New England Biolab, Beverly, MA, USA) and transfected into HCT116 p53 þ / þ cells using Lipofectamine 2000 (Invitrogen). Positive clones were selected by growing the cells in a concentration of 100 mg/ ml hygromycin. Cells were also stably transfected with the vector alone, selected with hygromycin and used as a control.
Western blot analysis
Protein extraction and Western blot analyses were performed using standard procedures. The membranes were immunoblotted with primary antibodies against KLF4 (Shields et al., 1996) , p53, p21
, cyclin E, or b-actin (Santa Cruz). Secondary antibody horseradish peroxidase-conjugated goat anti-rabbit IgG; 1 : 10000 dilutions (Santa Cruz).
Cyclin-dependent kinase 2 (Cdk2) assay
Cells in plate were washed twice with cold PBS, then 400 ml lysis buffer, PI (0.1% NP40, 50 mM HEPES, pH 7.0, 250 mM NaCl, 0.21% (w/v) NaF, 1 mM PMSF, 1 mg/ml each of pepstatin, leupeptin, and aprotinin) were added. Cells were then scraped of the plate, vortexed for 2 min followed by incubation on ice for 20 min. Cell debris was separated by centrifugation at maximum speed for 10 min at 41C. The supernatant was collected and the pellet discarded. To new tubes, 200 mg protein per sample was transferred and the volume was brought to 1 ml with lysis buffer PI. In total, 1 mg Cdk2 antibody per 100 mg protein was added and mixed. The mixture was then incubated with thorough gentle mixing for 1 h at 41C. In all, 25 ml of a 50% EZview Red protein G affinity gel beads slurry (Sigma) was aliquoted to clean tubes and washed twice and equilibrated with 750 ml lysis buffer PI. After the incubation, the mixtures were added to the equilibrated beads, vortexed briefly, and then incubated with thorough gentle mixing for 1 h at 41C. The tubes were centrifuged for 30 s at 8200 g to pellet the beads and the supernatant was discarded. The pellets were washed twice with lysis buffer PI, then equilibrated in kinase buffer (20 mM HEPES, pH 7.9, 5 mM MgCl 2 , and 10% glycerol). After equilibration, the beads were pelleted again, resuspended in 20 ml of kinase buffer containing 1 mM DTT, 500 mM ATP, and 1 mg histone H1 (Roche Applied Sciences, Indianapolis, IN, USA) and incubated for 30 min at 371C. The reaction was then stopped by adding 20 ml of 2 Â loading buffer per sample, and then heated in a boiling water bath for 10 min. Histone H1 phosphorylation was then detected by Western blot using a phospho-specific Histone H1 antibody (Calbiochem, San Diego, CA, USA) at 1.5 mg/ml. Secondary antibody against rabbit IgG was used at 1 : 5000 dilutions (Santa Cruz).
Cotransfection and reporter assays
Co-transfection experiments were performed in HCT116 p53À/À cells with a À363 to þ 1007 human cyclin E-luciferase reporter, pGL-cyclin E (À363 to þ 1007) (kindly provided by Dr Robert Weinberg) (Geng et al., 1996) , the expression construct containing KLF4, pMT3-KLF4 (Shields et al., 1996; Shields and Yang, 1997) , and the internal control Renilla luciferase, pRL-CMV (Promega). Transfection experiments were performed using lipofection (Yoon and Yang, 2004) . Luciferase activities were determined 2 days following transfection using the dual Luciferase Reporter Assay System (Promega). All firefly luciferase activities were normalized to the Renilla luciferase internal control.
Abbreviations BSA, bovine serum albumin; Cdk2, cyclin-dependent kinase 2; DPBS, Dulbecco's phosphate-buffered saline; FBS, fetal bovine serum; GKLF, gut-enriched Kru¨ppel-like factor; KLF4, Kru¨ppel-like factor 4; MEFs, mouse embryonic fibroblasts; PBS, phosphate-buffered saline; shRNA, small hairpin RNA.
